|
 |
FosamaxThis page contains recent news articles, when available, and an overview of Fosamax but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Fosamax (when available) Alendronate, a second-generation bisphosphonate is the first member of a group of drugs which strengthens bone. Alendronate is used to reduce hypercalcemia in tumor-induced bone disease, to treat corticosteroid-induced osteoporosis and Paget's disease, and to prevent osteoporosis in postmenopausal women. For the treatment and prevention of osteoporosis in women and Paget's disease of bone in both men and women Mechanism Of Action: The action of Alendronate on bone tissue is based partly on its affinity for hydroxyapatite, which is part of the mineral matrix of bone. Alendronate also targets farnesyl pyrophosphate (FPP) synthase. Nitrogen-containing bisphosphonates (such as pamidronate, alendronate, risedronate, ibandronate and zoledronate) appear to act as analogues of isoprenoid diphosphate lipids, thereby inhibiting FPP synthase, an enzyme in the mevalonate pathway. Inhibition of this enzyme in osteoclasts prevents the biosynthesis of isoprenoid lipids (FPP and GGPP) that are essential for the post-translational farnesylation and geranylgeranylation of small GTPase signalling proteins. This activity inhibits osteoclast activity and reduces bone resorption and turnover. In postmenopausal women, it reduces the elevated rate of bone turnover, leading to, on average, a net gain in bone mass. News Articles on Alendronate Health reform skepticism, Part I - 05 Jan 2010 Result: Medicare claims for screening exams rose from 77000 in 1994 to more than 1.5 million in 1999, according to Spiegel's report, and Fosamax ... Washington Post (blog) Options for Bone Loss, but No Magic Pill - Jan 4, 2010 The first drug licensed to counter osteoporosis, Fosamax, is now available generically as alendronate, which can be taken once a day or, at a higher dose, ... New York Times How Fosamax Got Into America's Medicine Cabinet - Dec 21, 2009 7:00 pm ET Katie Benghauser, 57, has been diagnosed with osteopenia and takes Fosamax as treatment to prevent osteoporosis. Katie Benghauser had no concept ... NPR Merck Names Tufts Dean Rosenblatt Chief Medical Officer - Dec 16, 2009 Rosenblatt is returning to Merck with the appointment--he helped lead development of the osteoporosis drug Fosamax and oversaw most of Merck's international ... Wall Street Journal Study Shows Mercks Fosamax May Fight Breast Cancer - Dec 11, 2009 ...s Fosamax, Warner Chilcott's Actonel, and Roche Holding AG's Boniva are commonly used by post-menopausal women to prevent bone loss. ... Portfolio.com (blog) The creation of a new "disease," osteopenia, to sell Merck's Fosamax - Jan 1, 2010 And it involves Merck selling a lot of Fosamax to women with the new "disorder" and making a lot of money. And it involves questions as to whether Fosamax ... OpEdNews Thinning Bones? How to Tell if You Need an Osteoporosis Medication - Dec 30, 2009 Fosamax, the first bisphosphonate, was approved in 1995. Some experts worry that while the drugs slow down bone loss, they may also slow down remodeling, ... U.S. News & World Report (blog) Merck loses effort to dismiss 24 Fosamax cases - Dec 11, 2009 A Manhattan federal judge has rejected Merck & Co's effort to dismiss 24 cases alleging that its Fosamax drug treatment for osteoporosis causes jaw damage. ... The Gazette (Montreal) Fosamax Jaw Necrosis Lawsuits in MDL Scheduled for Trial in April and June - Dec 15, 2009 US District Judge John Keenan, who is presiding over the consolidated federal Fosamax lawsuits involving claims that the osteoporosis drug caused users to ... AboutLawsuits.com Ladies, Pick Your Cancer - Dec 17, 2009 No wonder when the news broke last week that bisphosphonate bone drugs like Fosamax and Boniva could reduce the incidence of breast cancer, women reacted ... The Epoch Times Bone Drugs May Lower Risk for Breast Cancer - Dec 12, 2009 New results from a landmark women's health study raised the exciting possibility that bone-building medications such as Actonel and Fosamax may help lower ... HealthNews Bone density drugs may prevent breast cancer - Dec 28, 2009 A new study has revealed that bisphosphonates like Fosamax and Actonel taken by women may play a key role in preventing breast cancer. ... Biomed Middle East Health Matters: Bone-Strengthening Drugs Helping Breast Cancer? - Dec 15, 2009 Scientists looked at drugs including Fosamax, Actonel and Boniva -- and their affect on post-menopausal women. The lead researcher, at the Los Angeles ... WCTV Osteopororosis reversing drugs may prevent breast cancer - Dec 12, 2009 Data drawn from the ongoing Women's Health Initiative suggests that bone-building drugs (bisphosphonates) such a Fosamax®, Boniva®, and Actonel® may not ... Examiner.com Indian drug makers maintain pace of US marketing approvals - Jan 3, 2010 Drugs like Merck's Fosamax, Johnson & Johnson's Topamax, GlaxoSmithKline's Advair and Lamictal, Wyeth's Effexor XR, Astella's heart disease injection, ... Business Standard Vail Daily Wellness Words: Boosting bone density naturally - Dec 14, 2009 Currently, the manufacturer of the drug Fosamax, which is used in the treatment or prevention of osteoporosis, is involved in a trial with a class-action ... Vail Daily News Legal fight fails as NICE stands firm on osteoporosis guidance - Dec 10, 2009 Back in 2007, the National Institute for Health and Clinical Excellence recommended that doctors use Merck & Co's Fosamax (alendronate) as the first-line ... Pharma Times Some Brand-Name Patents: Going, Going, Gone in 2010 - Dec 29, 2009 Fortunately Merck has been through it before with the loss of Zocor and more recently Fosamax. AstraZeneca's breast cancer treatment Arimidex isn't quite as ... Motley Fool Today's Lady News: Houston Might Elect A Lesbian Mayor! - Dec 10, 2009 ...[New York Times Magazine] A study of 151000 women in the Women's Health Initiative found that those who took bone-building drugs, like Fosamax and Actonel, ... The Frisky The Obama effect and the year in medicine - Dec 30, 2009 One of the publications was titled The Australasian Journal of Bone and Joint Medicine and included glowing reviews of Merck's osteoporosis drug Fosamax and ... Globe and Mail Saving money on prescriptions - Dec 27, 2009 Albuterol (Ireland), Ambien CR (France), Cipro (Germany), Crestor (Japan and Puerto Rico), Flonase (Singapore), Fosamax D (Spain), Januvia (Italy), ... Tampa Tribune Economic news raises hopes for global recovery - Dec 11, 2009 ...results from a landmark women's health study raise the possibility that bone-building drugs such as Fosamax and Actonel may help prevent breast cancer. ... The Spokesman Review Drugs may increase risk for falls - Dec 15, 2009 Physicians who prescribe bone-building drugs like Actonel, Boniva and Fosamax also should be cautious about prescribing medications that might increase the ... The Spokesman Review 2009 Biotech Cheers and Jeers - Dec 22, 2009 ...waiting to launch Prolia into a market that's produced plenty of blockbusters, including Eli Lilly's (NYSE: LLY) Evista and Merck's (NYSE: MRK) Fosamax. ... Motley Fool Senate to review rules for prescription drug plan managers - Dec 11, 2009 So this writer asked the company about her own medication, Alendronate, the generic version of the drug Fosamax, taken by thousands of women to restore and ... Alaskajournal.com European experts recommend Amgen, Glaxo bone drug - Dec 18, 2009 N) Fosamax; Novartis's (NOVN.VX) Zometa; Actonel from Sanofi-Aventis (SASY.PA) and Procter & Gamble (PG.N); and Glaxo's own product Boniva or Bonviva, ... Reuters Merck Appoints Dr. Michael Rosenblatt As Executive Vice President & Chief ... - Dec 16, 2009 Laboratories where he co-led the worldwide development team for alendronate (FOSAMAX), Merck's bisphosphonate for osteoporosis and bone disorders. ... PharmiWeb.com (press release) Ennis & Ennis, PA Announces Nationwide Free Legal Consultations For Users of Paxil - Dec 16, 2009 The firm is currently investigating claims related to: Yaz Side Effects, Yasmin, Ocella, Accutane, Avandia, Fosamax, Reglan, Paxil, Plavix, Zimmer, Stryker, ... Behavioral Health Central (blog) Restructuration financière de la filiale marocaine de l'industriel ... - Jan 4, 2010 ...la rhumatologie (Fosamax...) et la pneumologie (Singulair). Rappelons que Merck & Co Inc vient de finaliser en novembre 2009 une méga-fusion avec son ... La Vie Éco Rắc rối, phiá»?n hà khi khám chữa bệnh BHYT theo luáºt má»›i - Jan 4, 2010 HCM) Ä‘ang chống nạng đứng đợi phát thuốc thì cô nhân viên thông báo thuốc Fosamax 70mg bác sÄ© kê toa sẽ được cấp vá»›i Ä‘iá»?u kiện bà phải có giấy chứng nháºn ... Tuổi Trẻ Fármacos para osteoporosis reducen riesgo cáncer de mama:estudio - Dec 11, 2009 Fosamax está disponible en su forma genérica, alendronato. Otros fármacos del mismo tipo son Boniva de Roche y Actonel que es vendido por Procter & Gamble ... Reuters América Latina 골다공ì¦? ì¹˜ë£Œì œ, ìœ ë°©ì•” ê°?소 효과 - Dec 10, 2009 ...'í?¬ì‚¬ë§¥ìŠ¤'(Fosamax, alendronate), '조메타'(Zometa, zoledronic acid), '본비바'(Bonviva, ibandronate)와 ê°™ì?€ 비스í?¬ìŠ¤í?¬ë„¤ì?´íŠ¸ 골다공ì¦? ì¹˜ë£Œì œê°€ 2ê°œ 연구 ê²°ê³¼ ... 디지틀보사 防骨質ç–?鬆藥 也能é??制乳癌 - Dec 11, 2009 ...這類藥包括å“?牌藥ç¦?善美(Fosamax)，其å¸å??藥為alendronate。 ç´?ç´„æ™‚å ±å ±å°Žï¼Œå°?「婦女å?¥åº·è¨ˆç•«ã€?è’?集的資料進行分æž?，以å?Šä»¥è‰²åˆ—å°?數å?ƒå??æ›´å¹´æœŸå¾Œå©¦å¥³é€²è¡Œçš„è§€å¯Ÿç ”ç©¶ï¼Œ ... 世界日報 Europe - Recommandation favorable pour le denosumab d'Amgen - Dec 18, 2009 Il sera en concurrence avec le Fosamax de Merck (MRK.N: Cotation), le Zometa de Novartis (NOVN.VX: Cotation), l'Actonel de Sanofi-Aventis (SASY. ... Reuters Thuốc chống loãng xÆ°Æ¡ng ngừa ung thÆ° vú - Dec 14, 2009 Kết quả cho thấy những ngÆ°á»?i dùng thuốc Fosamax hoặc các loại thuốc khác thuá»™c nhóm bisphosphonate, có rủi ro bị ung thÆ° vú thấp hÆ¡n 32% so vá»›i ngÆ°á»?i không ... Thanh Niên 여성건강ì—? í?¬ì†Œì‹? - Dec 12, 2009 Inc사ì?˜ ì œë„¤ë¦ ë²„ì „ 알약 í?¬ì‚¬ë§¥ìŠ¤(Fosamax)는 3개월 치가 100 달러ì?¸ 반면, 골다공ì¦?ì?„ 치료하기 위해 6개월 단위로 처방ë?˜ëŠ” ì •ë§¥ ì£¼ì‚¬ì œì?¸ Novartis AG사ì?˜ ì¡° ... 미주 한국일보 Medicametele pentru osteoporoza previn cancerul la san - Dec 12, 2009 Este vorba despre Fosamax si Actonel, ambele din familia bisfosfonatilor, despre care studiile au aratat ca previn cancerul la san, mai cu seama tipurile ... Ziare.com Препараты длÑ? укреплениÑ? коÑ?тей предотвращают рак молочной железы - Dec 12, 2009 Ð?едавнее иÑ?Ñ?ледование, проведенное американÑ?ким учеными, показало, что два препарата длÑ? укреплениÑ? коÑ?тей и поÑ?троениÑ? коÑ?тной маÑ?Ñ?Ñ‹ “Fosamaxâ€? и “Actonelâ€? ... Lenta.co.il Майкл Розенблатт назначен медицинÑ?ким директором «Merck&Co.» - Dec 18, 2009 в качеÑ?тве Ñ?таршего вице-президента по иÑ?Ñ?ледованиÑ?м, во времÑ? чего он был одним из руководителей международной команды по разработке препарата Fosamax ... Аптека online ConsultaÅ£ie la ginecolog pentru arsuri la stomac - Dec 14, 2009 Maria LupiÅ£u urma un tratament cu Digoxin, Tanakan, Tertensif, Sintrom, Diltiazem Eipico ÅŸi Fosamax în momentul în care au apărut durerile de stomac. ... Gazeta de Sud Top 10 reuÅŸite medicale ale anului 2009 - Dec 23, 2009 Nu se ÅŸtie însă dacă, după ce va fi aprobat, va fi mai eficient decât medicamentele existente, Fosamax, Boniva ÅŸi Reclast. Oamenii de ÅŸtiinţă au descoperit ... Realitatea Estudos: bisfosfonatos podem reduzir risco de cancro da mama - Dec 11, 2009 O Fosamax® (ácido alendrónico) da Merck Sharp & Dohme foi o medicamento mais usado nesta análise. Os especialistas acreditam que esta associação requer ... POP - Portal de Oncologia Portugês Top 10 phát minh y há»?c tiêu biểu nhất 2009 - Dec 17, 2009 Các loại thuốc chống loãng xÆ°Æ¡ng hiện có nhÆ° Fosamax, Boniva và Reclas thÆ°á»?ng nhắm và o tế bà o phá hủy xÆ°Æ¡ng nhÆ°ng nó vẫn còn tồn tại nhược Ä‘iểm. ... VNMedia Osteoporosis drugs pose extraction risk - 14 Nov 2009 My dentist is concerned with extracting the tooth because I have been taking Fosamax for osteoporosis the past five years. Should I be concerned about ... Reading Eagle Fracture risk gauges time on medicine - Nov 9, 2009 Dear Dr. Donohue: I am very worried about being taken off Fosamax. I have osteoporosis and have taken Fosamax for 11 years. My doctor said I don't need to ... Herald & Review Amgen Bone Drug Needs More Review by US Regulators - Oct 19, 2009 ...s Fosamax, generic versions of Fosamax, Roche Holding AG's Boniva and Novartis AG's Zometa. Denosumab should generate sales of $910 million in 2011 for ... Bloomberg Hormone Effective for Steroid-Induced Osteoporosis - Oct 29, 2009 ...fractures than those treated with alendronate, a bisphosphonate osteoporosis drug sold as Fosamax, an online article in Arthritis & Rheumatism reported. ... MedPage Today Zometa Lawsuit Over Jaw Necrosis Heading to Jury - Oct 20, 2009 The cases are similar to more than 900 Fosamax lawsuits that are pending against Merck & Co. over their oral bisphosphonate medication, which is used to ... AboutLawsuits.com Sticks & Stones and osteoporosis - Nov 7, 2009 The bone resorption inhibitor drug, just put on the market by Merck, is called Fosavance, and combines the vital vitamin with the company's Fosamax (sold in ... Jerusalem Post In Which You Get to Hear the Phrase "Hatch-Waxman" Again - Nov 2, 2009 ...(This, for example, is what happened when Teva broke into Merck's Fosamax patent, taking the drug generic about four years early). ... Corante (blog) Zometa Jaw Necrosis Lawsuit Results in $3.2M Verdict - Oct 23, 2009 The cases are similar to more than 900 Fosamax jaw necrosis lawsuits that are pending against Merck & Co. over their oral bisphosphonate medication. ... AboutLawsuits.com A Comprehensive Program for the Osteoporotic Patient - Oct 30, 2009 1 In recent news, the drug Fosamax, used in the treatment or prevention of osteoporosis, is being put on trial in a class-action lawsuit. ... Dynamic Chiropractic Plaintiff Wins First Zometa Trial - Oct 22, 2009 The first trial for the related drug Fosamax ended in a mistrial last month when the jurors could not reach a consensus. ONJ is a terrible and debilitating ... InjuryBoard.com (blog) Buy ALENDRONATE: Amazing prices!Great quality!Bonus pills added! Alendronate. - Oct 31, 2009 Common Fosamax side, effects. Other disorders affecting the ball of the day. If you are breast-feeding drug is not pharmacologically active. ... Newstalk ZB Merck posts big profit jump, slight rise in sales - Oct 22, 2009 HIV drug Isentress was up 84 percent to $197 million, but sales of osteoporosis blockbuster Fosamax, which now has generic competition, fell 22 percent to ... The Associated Press Merck Announces Third-Quarter 2009 Financial Results - Oct 22, 2009 Those sales include third quarter 2009 sales of $276 million for FOSAMAX and the $197 million in sales for ISENTRESS noted above. Worldwide sales of Merck's ... Reuters New Merck & Co opens for business - Nov 4, 2009 Generic competition against drugs like Singulair, Cozaar/Hyzaar, Fosamax and Zocor would be largely to blame for this decline. Despite new launches such as ... Pharmafocus Swine flu shot may ease pregnant mom's worries - Nov 2, 2009 Parathyroid hormone and medications like Fosamax, Boniva and Actonel may also be helpful for treatment of compression fractures and their prevention. ... Milwaukee Journal Sentinel At Frisbie Memorial Hospital: Doctor stresses need for calcium - Nov 2, 2009 Some, like calcitonin, only positively affect the spine, while others, like biphosphonates such as Fosamax, slow or stop bone loss, increase bone density ... Foster's Daily Democrat National osteoporosis day, a day of awareness - Oct 20, 2009 This includes Fosamax, Actonel and Boniva taken orally; and Boniva and Reclast taken intravenously. Each drug has its pluses and minuses and the choice ... Post Searchlight Wooly fern plant could treat osteoporosis, new research finds - Oct 29, 2009 As NaturalNews has previously reported, bisphosphonate drugs such as Fosamax which are widely hyped by Big Pharma as a solution to osteoporosis are rife ... Natural News.com (registration) Maybe Hatch-Waxman Data Exclusivity Isn't So Good For Traditional Drugs After All - Oct 18, 2009 Using Merck's Fosamax as an example, the authors state that Teva's successful Paragraph IV challenge permitted generic competition 4 years before Merck's ... Patent Docs (blog) Reportlinker Adds Regenerative Medicines: Bone and Joint Applications - Nov 3, 2009 AND CONDITIONS AFFECTING BONES 109 OSTEOPOROSIS 110 Currently Available Products to Treat Osteoporosis 111 Bisphosphonates 111 Fosamax 112 Boniva 113 ... IT News Online Remodeling of bone leads to Paget's disease - Oct 20, 2009 Medicines used for osteoporosis are used in Paget's disease — drugs like Reclast, Fosamax and Actonel. Dear Dr. Donohue — My husband died only minutes after ... St. Louis Post-Dispatch Merck & Co earnings climb as Januvia and Isentress impress - Oct 23, 2009 Sales of the osteoporosis drug Fosamax (alendronate) also fell 22% to $276 million, the result of patent protection loss in the USA. ... Pharma Times Farmacéuticas inventan enfermedades para vender medicamentos - Nov 8, 2009 ...gástrico) con $6 mil millones, Risperdal (para psicosis esquizofrénica) con $4 mil millones y Fosamax (para combatir osteoporosis) con $3 mil millones. ... Diario Digital Nuestro País Court rules Merck's Fosamax patent invalid - MarketWatch - Jan 28, 2005 By Val Brickates Kennedy, MarketWatch. BOSTON (MarketWatch) - A federal appeals court has ruled that a key patent on Merck's top-selling drug, Fosamax, ... MarketWatch New Worries Over Blockbuster Meds Avandia, Fosamax - Apr 28, 2008 By Amanda Gardner. MONDAY, April 28 (HealthDay News) -- Avandia and Fosamax, widely prescribed drugs used to treat two common health conditions, ... Washington Post It's okay to stop taking Fosamax for 5 years - Dec 27, 2006 BEIJING, Dec. 27 (Xinhuanet) -- A long-term study has found tens of millions of post-menopausal women worldwide can stop taking the most widely prescribed ... æ–°å?Žç½‘ 3 generic versions of Fosamax launched - Feb 6, 2008 TRENTON, NJ (AP) - At least three generic versions of the popular osteoporosis treatment Fosamax are headed for pharmacy shelves with the expiration of the ... Forbes Forteo fares better than Fosamax in Lilly study - Nov 14, 2007 BOSTON, Nov 14 (Reuters) - Forteo, the injected osteoporosis drug from Eli Lilly and Co (LLY.N), is better for preserving the bones of people taking ... Reuters Fosamax Linked to Unusual Femur Fractures - Mar 19, 2008 By Serena Gordon. WEDNESDAY, March 19 (HealthDay News) -- In the latest research to cast a shadow on the safety of a popular bone-strengthening medication, ... Washington Post Merck's Fosamax Court Defeat 'Widely Expected' - Oct 17, 2005 Bear Stearns said a US Supreme Court ruling Monday to reject a Merck (nyse: MRK - news - people ) appeal to retain a patent for blockbuster osteoporosis ... Forbes Lawyers gear up to attack Fosamax ; Lawsuits targeting osteoporosis … - Jul 10, 2006 As Merck & Co. defends itself against a deluge of litigation involving its pain reliever Vioxx, the pharmaceutical giant also is fielding the first of what ... Pay-Per-View - Chicago Tribune - ProQuest Archiver Bone-building drug needed just once a year. - May 2, 2007 Zometa and Fosamax are part of the most popular, effective class of such drugs, ... On Fosamax, her esophagus became scarred and narrowed, a complication ... Free with registration - Philadelphia Inquirer - AccessMyLibrary.com Merck Gets Fosamax Plus D Approval - Apr 8, 2005 By Althea Chang. The Food and Drug Administration approved the once-weekly Fosamax Plus D, an osteoporosis treatment containing the drug Fosamax and seven ... TheStreet.com - TheStreet.com (subscription) Fosamax Break Won't Up Fracture Risk - Dec 26, 2006 By none. (WebMD) After five years of taking the osteoporosis drug Fosamax, some women will be getting a break. That's "break" as in "drug holiday," not as ... CBS News Merck signs generic deal for Fosamax - Jan 11, 2008 PHILADELPHIA—Merck & Co. said Friday it has reached a deal with an unidentified company to market a copycat version of its blockbuster osteoporosis drug ... Boston Globe Fosamax Users Seek Class-Action Status - Nov 30, 2007 By LARRY NEUMEISTER, AP Writer. Lawyers for Fosamax users who believe their jaws were damaged by the osteoporosis drug on Friday asked a federal judge to ... San Francisco Chronicle Roche, GSK's Boniva to go head-to-head with Merck's Fosamax - Sep 27, 2005 ZURICH (AFX) - Roche Holding AG and GlaxoSmithKline PLC said they plan a large scale clinical trial comparing their osteoporosis drug Boniva with the market ... Forbes Amgen says denosumab improves bone vs Fosamax - May 20, 2008 LOS ANGELES (Reuters) - Amgen Inc (AMGN.O: Quote, Profile, Research) said on Monday a trial of its experimental osteoporosis drug, denosumab, ... Reuters UK Merck Sued Over Fosamax Health Risks - Apr 11, 2006 Merck & Co., which faces more than 9000 lawsuits over its Vioxx painkiller, misrepresented the safety of its osteoporosis drug Fosamax by withholding ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Merck Sued in Canada Over Fosamax Drug, Law Firm Says - May 28, 2007 By Joe Schneider. May 28 (Bloomberg) -- Merck & Co., the drugmaker defending about 27000 lawsuits filed by users of the painkiller Vioxx, was accused in a ... Bloomberg Watson to ship generic Fosamax under Merck deal - Feb 5, 2008 NEW YORK, Feb 5 (Reuters) - Watson Pharmaceuticals Inc (WPI.N) said on Tuesday it will sell a US generic version of Merck & Co's (MRK. ... Reuters Former Fosamax patients blame drug for causing rare disease - May. 9,... - May 8, 2006 With thousands of Vioxx cases already in the courts, the drugmaker faces 15 suits over an osteoporosis drug blamed for rotting the jaw bone. ... CNNMoney.com … Aurobindo Pharma gets US FDA final approval for generic Fosamax - Aug 5, 2008 ...the United States Food and Drug Administration to make and market a generic version of Merck & Co Inc.'s Fosamax, known as Alendronate Sodium tablets. ... Forbes Can Fosamax, the osteoporosis drug, damage the jaw? - Aug 28, 2006 In rare cases, bisphosphonates, the class of medicines to which Fosamax belongs, have been linked to the death of jaw bone tissue. ... Boston Globe Plotting to Save the Structure of Those Aging Bones - Jul 5, 2005 Several drugs in the bisphosphonate class - Fosamax and Actonel taken weekly and ... A report in the same journal described nine patients on Fosamax with ... New York Times Merck reaffirms 2007 profit outlook - Dec 4, 2007 ...“Despite the loss of marketing exclusivity for Fosamax in the United States in February 2008, the company anticipates solid earnings growth in 2008,â€? said ... msnbc.com … Sun Pharma gets US FDA approval for generic of Merck's Fosamax - Sep 12, 2008 MUMBAI (Thomson Financial) - India's Sun Pharma Ltd. said it has won final approval from the US Food & Drug Administration (FDA) for its generic version of ... Forbes Roche, GSK Say FDA OKs Monthly Osteoporosis Drug - Mar 28, 2005 Most of the drug's rivals -- including Merck & Co Inc.'s (MRK) Fosamax (search) ... Fosamax sold $3.2 billion worldwide in 2004 while Actonel raked in about ... FOXNews Merck reports lower earnings on charges - Jan 30, 2007 Clark said that the company now faces about 104 cases over Fosamax, ... Clark emphasized that Fosamax has been on the market for over 10 years and that ... MarketWatch Correction to This Article - Jun 11, 2007 The NEJM study found such a link for another drug in Fosamax's class, but not for Fosamax. The earlier study found the suggestion of a trend between Fosamax ... Washington Post FDA OKs First Generic Fosamax - Feb 6, 2008 By Miranda Hitti. Feb. 6, 2008 -- The FDA today approved the first generic versions of the osteoporosis drug Fosamax (alendronate). ... WebMD Vioxx, Fosamax comparisons are too early, experts caution | Article... - Apr 23, 2006 Vioxx, Fosamax comparisons are too early, experts caution ... find The Record (Bergen County, NJ) articles. DUNSTAN PRIAL, STAFF WRITER The Record (Bergen ... Pay-Per-View - The Record - HighBeam Research SEC Probe, Patent Denial Hit Merck - Jan 31, 2005 ..."The stock decline is justified by the news because Fosamax (search) is the ... The ruling on Fosamax means Merck's earnings could take another hit in 2008 ... FOXNews Study finds Amgen bone drug reduces fractures - Sep 17, 2008 The top-selling treatment for osteoporosis has been Merck's Fosamax, ... The generic form of Fosamax, alendronate, is required by many health insurers as ... Los Angeles Times Fosamax lawsuit brings risks to light - Jun 20, 2006 Pamela Hines went from an active lifestyle of running five miles a day and working full-time to being unable to eat most foods and feeling constant pain. ... $2.95 - Salt Lake Tribune, The - NewsBank Amgen's Denosumab Outperforms Fosamax In Trials - Nov 15, 2005 Piper Jaffray reiterated an "outperform" rating and $88 target price on Amgen (nasdaq: AMGN - news - people ), citing positive two-year data for the ... Forbes … & Co wins EU patent reinstatement on osteoporosis blockbuster Fosama... - Mar 29, 2007 LONDON (AFX) - Merck & Co Inc said it has obtained a new European patent for its osteoporosis drug Fosamax, which had sales of more than 3 bln usd last year ... Forbes Merck's patent for Fosamax finally runs out - Feb. 5, 2008 - Feb 5, 2008 Another day, another blockbuster falls off the cliff, as Merck bids farewell to the Fosamax patent and $3 billion in annual sales. ... CNNMoney.com Merck faces suit over Fosamax - Apr 13, 2006 By AP | April 13, 2006. NEW YORK -- Merck & Co, which is already facing a raft of cases over its pain reliever Vioxx, may need to hire additional attorneys ... Boston Globe New Merck chief plans for long-term recovery - Oct 25, 2005 The company also reported disappointing sales of Fosamax, ... However, the gains were pared as news of the failed Fosamax appeal dampened demand. ... Times Online Article: Retired in Rochester So glad ... - The Washington Post | … - Jun 19, 2007 The FOSAMAX Once-Weekly patent expires ... decision is subject to appeal. FOSAMAX is the world's leading non ... of our Form 10-K for the year ended Dec. ... Pay-Per-View - Washington Post - HighBeam Research Judge denies class in Fosamax cases against Merck - Jan 4, 2008 NEW YORK (Reuters) - A US federal judge has denied motions to certify classes of users of osteoporosis drug Fosamax who wanted Merck & Co (MRK. ... Reuters Lawsuit claims Fosamax caused tissue disease - Apr 15, 2006 By LIZ FREEMAN. Like thousands of women in their 50s, Linda Secrest developed osteoporosis and her doctor prescribed Fosamax, a medication to reverse bone ... Naples Daily News - Naples Daily News A double dose of Fosamax - Apr 11, 2005 Question: I have been taking Fosamax 70 milligrams twice a week instead of once weekly on the advice of my endocrinologist. ... $2.95 - Philadelphia Inquirer - NewsBank Merck's Revenue Increases, but Charges Eat Into Profit - Jan 31, 2007 Merck, the maker of the osteoporosis treatment Fosamax and the asthma drug Singulair, reported net income of $473.9 million, or 22 cents a share, ... New York Times Merck Q2 profit more than doubles - Jul 24, 2006 The maker of osteoporosis treatment Fosamax and Singulair for asthma and allergies ... Singulair sales jumped 30% to $950 million; Fosamax sales dipped ... USA Today Fosamax, anti-inflammatory drugs can raise risk of stomach ulcers - Jul 28, 2008 By PEOPLE'S PHARMACY|July 28, 2008. Five years ago, I developed duodenal ulcers after taking Fosamax for six weeks. I was also taking ibuprofen for ... Los Angeles Times Higher sales, lower costs send Merck's profit up 62% - Oct 22, 2007 The maker of osteoporosis treatment Fosamax and Singulair for asthma and allergies reported net income of $1.53 billion, or 70 cents a share, for the three ... USA Today Be cautious about medications offered for bone thinning - May 17, 2005 Between 2002 and 2003, worldwide sales of Fosamax, used to prevent bone loss, ... Should a woman at 50 start taking drugs like Fosamax, Actonel or Evista to ... Boston Globe Merck reports jump in quarterly profit - Earnings - MSNBC.com - Apr 20, 2006 The maker of blockbusters Fosamax for osteoporosis and Zocor for high cholesterol said net income totaled $1.52 billion, or 69 cents per share, ... msnbc.com Merck first-quarter net jumps 12% on higher sales - Apr 19, 2007 The maker of Fosamax for osteoporosis and Singulair for asthma and ... Sales of Singulair jumped 25% to $1 billion, while Fosamax sales dipped 2% to $742 ... USA Today Well - A Rare Type of Leg Fracture Is Linked to Osteoporosis Drugs - ... - Jul 15, 2008 Nineteen had been using the bone drug Fosamax for an average of 6.9 years. ... Merck, which makes Fosamax, says it will study whether the unusual fracture ... New York Times Merck Shows Some Upside | Robert Steyer News | Print Financial & … - Oct 24, 2005 Sales of the Fosamax osteoporosis medication were flat at $777 million. The latest quarter includes costs of $80 million relating to cutting 825 jobs. ... TheStreet.com - TheStreet.com (subscription) Amgen building stronger bones - Feb 23, 2006 The drug appeared to work at least as well as Merck's Fosamax, ... If approved, denosumab would compete with Fosamax, which must be taken weekly, ... Rocky Mountain News Merck Announces First-Quarter 2005 Earnings Per Share -EPS- of 62 … - Apr 21, 2005 FOSAMAX continued to be the most-prescribed medicine worldwide for the treatment of ... US mail-order-adjusted prescription levels for FOSAMAX increased by ... Free with registration - Business Wire - AccessMyLibrary.com Merck posts loss due to Vioxx settlement - Jan 30, 2008 Sales edged up just 1 percent to $796 million for Fosamax, which loses patent protection on Feb. 6. Merck has an agreement with another company to produce ... msnbc.com Merck: Sales Up, Restructuring on Track - Dec 11, 2007 ..."With our 2007 and 2008 guidance, it is clear that our products are driving a healthy top line despite lapping the Zocor expiry and the upcoming Fosamax ... FOXNews Amgen Drug Improves Bone Density in Study - May 28, 2008 1.6% in the Fosamax arm. Amgen reported in January that the study met the primary and secondary endpoints and that adverse events were comparable between ... TheStreet.com - TheStreet.com (subscription) Report Links Osteoporosis Drug to Esophagus Cancer - Dec 31, 2008 However, Wysowski acknowledged to ABCNews.com that it still remains uncertain whether Fosamax and other oral bisphosphonates can be linked to esophageal ... ABC News BRIEFLY; Fosamax seen as better bone boost - Aug 21, 2006 The Merck and Co. drug Fosamax does a better job at preventing bone deterioration than vitamin D for people using steroids to treat arthritis, ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Merck wins Fosamax dispute with Apotex - Jul 16, 2008 WASHINGTON, July 16 (Reuters) - Merck & Co Inc (MRK.N) won a fight with Apotex over the osteoporosis drug Fosamax when a patent appeals court ruled on ... Reuters Amgen says denosumab vs Fosamax trial meets goals - Jan 24, 2008 LOS ANGELES, Jan 24 (Reuters) - Amgen Inc (AMGN.O)said on Thursday that a head-to-head trial comparing its experimental osteoporosis drug denosumab to Merck ... Reuters FDA approves FOSAMAX PLUS D for Osteoporosis - Apr 12, 2005 Merck & Co, Inc. announced today that the US Food and Drug Administration (FDA) has approved FOSAMAX PLUS DTM -. (alendronate sodium/cholecalciferol) ... Medical News Today - Medical News Today (press release) Merck profit almost doubles in 1Q on gain - Apr 21, 2008 Its osteoporosis treatment Fosamax, which had been the leading drug in the category and one of Merck's top sellers, got new generic competition. ... San Diego Union - Tribune - San Diego Union Tribune US officials issue alert for osteoporosis medications - Jan 7, 2008 The US Food and Drug Administration said the alert affects bisphosphonates, which includes Fosamax, Zometa and Actonel. Patients may begin feeling pain ... CBC.ca Osteoporosis, osteopenia screening and prevention are best done when ... - Sep 22, 2008 Suddenly, there were drugs available, Fosamax being the first in 1995 of a ... Fosamax was promoting this whole thing, and most of the ob-gyns were on the ... Los Angeles Times Teva: Belgian court revokes Merck Sharp's European patent on Fosamax - Apr 11, 2008 NEW YORK (Thomson Financial) - Teva Pharmaceutical Industries Ltd. Friday said a Belgian court has revoked the Belgian part of Merck Sharp & Dohme's ... Forbes Merck Raises Profit Targets - Jul 20, 2007 The Fosamax family of osteoporosis drugs saw sales decline 4% to $786 million. Along with raising its overall outlook, Merck lifted its full-year sales ... TheStreet.com - TheStreet.com (subscription) … HAZARDS DOCTORS RAISE CONCERNS OVER USE OF FOSAMAX. - May 20, 2006 Informational box at end of text. Millions of midlife and older Americans rely on the medication Fosamax to stave off osteoporosis, a crippling disease that ... Pay-Per-View - South Florida Sun - Sentinel - ProQuest Archiver Merck to Discount Drugs for Uninsured - Apr 20, 2005 For instance, Merck will discount Fosamax, its popular treatment for ... The average insurance co-payment for Fosamax is about $22, Merck officials said. ... Washington Post Amgen up on osteo drug vs. Merck's Fosamax - Jan 25, 2008 ...by The Star-Ledger Business Desk. Shares to watch in active trading today include biotechnology company Amgen, which posted higher quarterly earnings ... nj.com Short takes Generic drug prices falling in US - Dec 11, 2008 ...particularly intense for drugs that had been brand-name block busters — recent examples include osteoporosis drug Fosamax and cholesterol fighter Zocor. ... Reading Eagle - Google News Archive Teva says 2 courts revoke Merck patent - Feb 25, 2008 Israeli-based Teva is already marketing Fosamax, also known as alendronate, at 10 milligrams and 70 milligrams in various European countries. ... Forbes Merck's CEO Praises Progress - Apr 11, 2006 Sales of the osteoporosis drug Fosamax lost 2% to $754 million. Fosamax has begun to be hit by generic competition in some foreign markets. ... TheStreet.com - TheStreet.com (subscription) Fosamax risk weighed - A few cases link drugs for osteoporosis to … - Jun 19, 2006 Graphic designer Patricia Korch settled into her oral surgeon's chair, ready to have a troublesome tooth extracted as part of orthodontia she'd delayed for ... $1.95 - Worcester Telegram Gazette - NewsBank Drug data could boost Amgen - Jul 25, 2008 While bisphosphonates such as Fosamax, which had $3 billion in sales in 2007, are usually given once a week orally, Denosumab would have to be given only ... Seattle Post-Intelligencer - Seattle Post Intelligencer Ask the doctor; Does Fosamax cause atrial fibrillation? - Oct 1, 2007 Q. I am 86 years old and have been taking Fosamax to strengthen my bones for nearly 10 years. A few months ago, I suddenly fainted and was later diagnosed ... $4.95 - Harvard Heart Letter - ECNext PREVIEW-Investors await crucial bone drug data from Amgen - Sep 12, 2008 N) Fosamax, Sanofi-Aventis SA (SASY.PA) and Procter & Gamble Co's (PG.N) Actonel, Novartis AG's (NOVN.VX) Reclast, and Boniva, from Roche Holding AG (ROG. ... Reuters Stronger bones can be grown, study says. - Aug 11, 2005 Taking Fosamax after a course of parathyroid hormone "is clearly an effective sequence," said Dr. Felicia Cosman, clinical director of the National ... Free with registration - San Jose Mercury News - AccessMyLibrary.com Analysis: Lilly's Forteo may be too costly - Jun 12, 2006 ..."Forteo was not cost-effective compared to Fosamax because of it's high price," the study's lead author, Hau Liu of Stanford University's Center for Health ... United Press International FDA approves FOSAMAX PLUS D for Osteoporosis - Apr 13, 2005 ...(I-Newswire) - ( alendronate sodium/cholecalciferol ), a single once-weekly tablet containing 70 mg FOSAMAX® ( alendronate sodium ) and 2800 IU vitamin D3, ... i-newswire.com Merck still fighting for Fosamax - Apr. 21, 2005 - Apr 21, 2005 NEW YORK (CNN/Money) - A US appeals court rejected Merck & Co.'s request to reconsider the patent expiration on its profitable drug Fosamax, but the company ... CNNMoney.com Merck's third-quarter net drops 34 percent - Oct 20, 2006 Merck, the maker of osteoporosis treatment Fosamax as well as Singulair for asthma and allergies, reported net income of $941 million, or 43 cents per share ... msnbc.com Injured By Fosamax? . - Jun 11, 2006 Injured by Fosamax? death" and other serious side effects have been associated with the use of the drug Fosamax. This drug has been commonly prescribed to ... Pittsburgh Post-Gazette - Google News Archive Injured By Fosamax? . - Jun 7, 2006 Injured by Fosamax? death" and other serious side effects have been ... of the drug Fosamax. This drug has been commonly prescribed to prevent bone loss due ... Pittsburgh Post-Gazette - Google News Archive Drug linked to death of jawbone ; FDA review cites risk with oral, IV... - Mar 14, 2005 Six had taken Fosamax, and a seventh had taken Actonel, another oral bisphosphonate for osteoporosis. The problem doesn't appear to be as severe with oral ... Pay-Per-View - USA TODAY - ProQuest Archiver Merck Beats, but Offers No Forward Guidance - Jul 21, 2008 However, sales of bone drug Fosamax and Fosamax Plus D fell 48% to $411 million, due to a loss of market exclusivity for most formulations in the US ... TheStreet.com - TheStreet.com (subscription) Drug Strengthens Women's Bones . - May 3, 2007 Although drugs such as Fosamax and Actonel are effective at preventing bone loss and re ducing the major health risks as sociated with fractures, ... Sarasota Herald-Tribune - Google News Archive Article: NJ BRIEFS - The Record (Bergen County, NJ) | HighBeam … - Apr 11, 2006 According to the Fosamax suit, Secrest began taking the drug in 2000 and was ... In addition, Loder said claims of jawbone tissue death caused by Fosamax ... Pay-Per-View - The Record - HighBeam Research Head-to-head comparison of Forteo and Fosamax - Nov 15, 2007 The osteoporosis drug Forteo works better than Fosamax to strengthen bones in arthritis patients with prednisone-induced osteoporosis, according to a new ... News-Medical.net Studies do not link heart risk to bone drugs: FDA - Nov 12, 2008 The agency reviewed studies on Merck & Co's Fosamax, Roche's Boniva, Novartis AG's Reclast and Procter and Gamble Co's Actonel and found heart rhythm ... Reuters India Fosamax from Canadian Pharmacy - Jun 16, 2007 ...by pharmaceutical companies may do a number of things:[2] * Carefully research Fosamax demand for their potential new product Fosamax spending an outlay of ... Sokwanele Drug prices up in first months of Medicare plans - Jun 20, 2006 ...raised their prices for cholesterol drug Zocor in 40-milligram formulations, and 99% hiked the price of osteoporosis-fighting, 70-milligram Fosamax. ... MarketWatch Fosamax Without A Prescription - Jun 15, 2007 ...the United States, the Food and Drug Fosamax Without A Prescription and they enforce standards set by the federal Prescription Drug Marketing Act (PDMA) ... Sokwanele Medicare drug plan spending drops $6B in 2008 - Oct 30, 2008 Norvasc, for high blood pressure, and Fosamax, for osteoporosis, are among expensive drugs now available in generic form. Generics account for 64% of ... USA Today About the drug . - Jun 1, 2006 Those drugs Fosamax, Actonel and— reduce the risk of— debilitating fractures of the spine and broken hips. Only 15 cases of osteonecrosis have been ... Herald-Tribune - Google News Archive Merck Win Could Weed Out Suits With Less Merit - Nov 3, 2005 ...as Zocor loses exclusivity in 2006 followed by Fosamax in 2008," said Goldstein. "The win is a positive, but additional risk from other trials exists." ... Forbes Order Fosamax COD - Aug 24, 2007 ...for their potential new product before spending an outlay of Order Fosamax COD funds.[2] * Obtain a patent on the Order Fosamax COD on the chemical (eg ... Sokwanele New Drug May Strengthen Women's Bones - Oct 26, 2008 Alendronate (brand name Fosamax) is commonly used in the prevention and treatment of osteoporosis in postmenopausal women. ... Forbes $225m boost to tackle scourge of osteoporosis - Dec 18, 2006 She said an application was made to list Fosamax on the PBS for preventative use three years ago. "However the PBS listing has stalled because its ... The Age Big Vioxx charge hits profit, stock - Jan 31, 2008 The maker of allergy and asthma pill Singulair and osteoporosis treatment Fosamax said the net loss amounted to 75 cents per share, compared with a year-ago ... Pay-Per-View - Toronto Star - ProQuest Archiver Amgen updates progress of important experimental drug - Sep 29, 2007 N) as Fosamax, for treatment of post menopausal osteoporosis and to begin analysis in February. The update on the pipeline was given by Amgen's executive ... Reuters UK Once-Yearly Osteoporosis Drug In Works - Sep 19, 2006 The other 112 women took Fosamax pills once weekly. A third of the women in the Reclast group reported side effects within the first three days after ... CBS News Brand Names/Synonyms: Fosamax is also known by the following brand names and/or synonymsALENDRONIC ACID; Acide Alendronique [Inn-French]; Acido Alendronico [Inn-Spanish]; Acidum Alendronicum [Inn-Latin]; Adronat; Alendronate; Alendronate Sodium; Alendronic Acid; Alendronic Acid [Ban:Inn]; Alendros; Arendal; CHEMBANK1709; Fosamax; MK 217; Onclast Drug Category: Fosamax is categorized under the following by the FDA: Antiresorptives; Bisphosphonates; Antihypocalcemic Agents; ATC:M05BA04 Dosage Forms: 10 mg (Rx) Fosamax lactose 40 mg (Rx) Fosamax lactose Absorption: Relative to an intravenous (IV) reference dose, the mean oral bioavailability of alendronate in women was 0.7% for doses ranging from 5 to 40 mg when administered after an overnight fast and two hours before a standardized breakfast. Oral bioavailability of the 10 mg tablet in men (0.59%) was similar to that in women (0.78%) when administered after an overnight fast and 2 hours before breakfast. Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: (4-amino-1-hydroxy-1-phosphono-butyl)phosphonic acid |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |